Prosthetic (Prosthesis) devices, such as an artificial leg, that replace a part of the body. Prostheses are typically used to replace parts lost by injury (traumatic) or missing from birth (congenital) or to supplement defective body parts. Inside the body, artificial heart valves are in common use with artificial hearts and lungs seeing less common use but under active technology development. Other medical devices and aids that can be considered prosthetics include artificial eyes, palatal obturator, gastric bands, and dentures.
Replacing both knees in one surgery, or simultaneous total knee replacement was associated with significantly fewer prosthetic joint infections as well as other revision knee operations within one year after surgery, compared with total knee replacements performed in two separate procedures.
Four of the nation's leading veterans service organizations are urging the Administration and Congress to invest $65.3 billion to sufficiently meet veterans health-care and veterans benefits needs. For the Department of Veterans Affairs, the administration has proposed $61.9 billion in discretionary spending for fiscal year 2012. The budget proposal now goes to Congress for consideration.
The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association and the Heart Rhythm Society.
Two artificial big toes - one found attached to the foot of an ancient Egyptian mummy - may have been the world's earliest functional prosthetic body parts, says the scientist who tested replicas on volunteers.
DENTSPLY International Inc. today announced sales and earnings for the three months and year ended December 31, 2010.
Tiny, implantable computers that would restore brain function lost to disease or injury is the goal of University of Washington research recently funded by a $1 million, three-year grant from the W.M. Keck Foundation.
Today the U.S. Food and Drug Administration proposed the Innovation Pathway, a priority review program for new, breakthrough medical devices and announced the first submission: a brain-controlled, upper-extremity prosthetic that will serve as a pilot for the program. The FDA also announced plans to seek further public comment before the Pathway can be used more broadly.
Congenital heart defects are the most common type of major birth defects in the U.S., affecting about 34,000 babies each year. Twenty percent of these patients are born with a malformation of the pulmonary valve, which is a flap-like opening on the right side of the heart that is responsible for regulating the blood flow to the lungs. Now, a new replacement valve being used at Rush University Medical Center can help patients with damaged heart valves delay or avoid multiple open-heart surgeries.
Sonitus Medical, Inc., a medical device company that manufactures the world's first non-surgical and removable hearing prosthetic to transmit sound via the teeth, today announced that it has received FDA clearance for its SoundBite Hearing System. The FDA 510(k) clearance is the first for the company and the product.
On-X Life Technologies, announced today that it has received approval from the U.S. Food and Drug Administration to market the On-X Ascending Aortic Prosthesis with the Vascutek Gelweave Valsalva Graft.
University of Rochester Medical Center orthopaedic scientists are a step closer to developing a vaccine to prevent life-threatening methicillin-resistant staphylococcus aureus (MRSA) infections following bone and joint surgery.
The Internet, smart phones and teens' endless search for self-acceptance in their technology connected yet isolated world is driving a revival of substance abuse of salvia, an herb from flower seeds that induces psychedelic effects but is not detectable with usual drug tests, and synthetic cannabis, a psychoactive herbal and chemical concoction, also undetectable, popularly known around high schools as "spice".
University of Houston researchers are helping the Pentagon build reliable mind-controlled prosthetic devices that military and civilian amputees can use the rest of their lives.
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD), announced today it has closed a Series E financing totaling $31 million.
El Camino Hospital today announced its first patient implant in the Medtronic CoreValve® U.S. Clinical Trial.
Since 2003, 1,145 soldiers serving in Iraq and Afghanistan have had a limb amputated. In response, Alion Science and Technology, an employee-owned technology solutions company, is leading a modeling and simulation research effort that could help enhance the field of prosthetic limbs. Alion was awarded an 18-month, $1.4 million contract from the U.S. Army Medical Research Acquisition Activity to explore affordable and improved approaches in bringing robotic control technology to the field of prosthetic limbs.
On-X® Life Technologies, Inc., today announced the publication of results of a large, prospective multi-center Canadian trial with the On-X® Prosthetic Heart Valve in the November issue of The Journal of Thoracic and Cardiovascular Surgery.1 According to the results of the report, "The On-X mechanical prosthesis provides favorable intermediate-term results with regard to major thromboembolism, hemorrhage and composites of valve-related complications."
News briefs concerning economic and business growth in the Tampa Bay region from the Tampa Bay Partnership:
Hanger Orthopedic Group, Inc. announced today the pricing of the previously announced public offering of 2,000,000 shares of its common stock by Ares Corporate Opportunities Fund, L.P. at a public offering price of $20.00 per share. The transaction is expected to close on December 15, 2010. The shares sold were a portion of the currently outstanding shares issued to Ares in August 2008 in connection with the conversion of all of Hanger's Series A Convertible Preferred Stock into common stock.
Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, announced its new MS Specialty Program, which includes physical therapy services and a health and wellness program designed to reduce or alleviate the symptoms of MS for patients, available in its more than 600 clinics throughout the United States.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.